TARRYTOWN, N.Y. and CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has ...

The exact cause of polymyalgia rheumatica (PMR) is unknown. Studies of patients with PMR and giant-cell arteritis indicate that PMR could be a vasculitis limited to the subclavian or axillary arteries ...

The increasing prevalence of polymyalgia rheumatica among the elderly population is boosting the adoption of polymyalgia rheumatica treatment to efficiently control painful myalgia. Furthermore, the ...

Treatment with glucocorticoids can resolve most cases of polymyalgia rheumatica within 2 years; however, a minority of patients have a chronic, relapsing form of the disease and require long-term ...

Clinicians may have an ambivalent attitude about polymyalgia rheumatica, a disabling disease marked by severe muscle pain and stiffness. On the one hand, it is most rewarding to be able to almost ...

PORTLAND, Ore.--(BUSINESS WIRE)--Sparrow Pharmaceuticals today presented data from an ongoing Phase 2 clinical trial of HSD-1 inhibitor clofutriben (SPI-62) and prednisolone in patients with ...

Dr John Watterson, MD, FRCPC, discusses what is polymyalgia rheumatica. Suspect sent text saying he would 'take out' Charlie Kirk, FBI says as scrutiny of Patel's performance increases Desi Arnaz: ...